MetLife Statistics
Total Valuation
MetLife has a market cap or net worth of $54.11 billion. The enterprise value is $79.88 billion.
Important Dates
The next estimated earnings date is Wednesday, October 29, 2025, after market close.
Earnings Date | Oct 29, 2025 |
Ex-Dividend Date | Aug 5, 2025 |
Share Statistics
MetLife has 665.03 million shares outstanding. The number of shares has decreased by -6.05% in one year.
Current Share Class | 665.03M |
Shares Outstanding | 665.03M |
Shares Change (YoY) | -6.05% |
Shares Change (QoQ) | -1.75% |
Owned by Insiders (%) | 0.22% |
Owned by Institutions (%) | 75.22% |
Float | 554.69M |
Valuation Ratios
The trailing PE ratio is 13.73 and the forward PE ratio is 8.62. MetLife's PEG ratio is 0.67.
PE Ratio | 13.73 |
Forward PE | 8.62 |
PS Ratio | 0.76 |
Forward PS | 0.70 |
PB Ratio | 1.96 |
P/TBV Ratio | 2.92 |
P/FCF Ratio | n/a |
P/OCF Ratio | 3.55 |
PEG Ratio | 0.67 |
Financial Ratio History Enterprise Valuation
EV / Earnings | 19.53 |
EV / Sales | 1.09 |
EV / EBITDA | 11.02 |
EV / EBIT | 12.22 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.62, with a Debt / Equity ratio of 1.72.
Current Ratio | 1.62 |
Quick Ratio | 1.37 |
Debt / Equity | 1.72 |
Debt / EBITDA | 6.45 |
Debt / FCF | n/a |
Interest Coverage | 6.27 |
Financial Efficiency
Return on equity (ROE) is 15.51% and return on invested capital (ROIC) is 5.40%.
Return on Equity (ROE) | 15.51% |
Return on Assets (ROA) | 0.59% |
Return on Invested Capital (ROIC) | 5.40% |
Return on Capital Employed (ROCE) | 1.00% |
Revenue Per Employee | $1.62M |
Profits Per Employee | $90,911 |
Employee Count | 45,000 |
Asset Turnover | 0.11 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, MetLife has paid $1.41 billion in taxes.
Income Tax | 1.41B |
Effective Tax Rate | 24.66% |
Stock Price Statistics
The stock price has increased by +7.41% in the last 52 weeks. The beta is 0.83, so MetLife's price volatility has been lower than the market average.
Beta (5Y) | 0.83 |
52-Week Price Change | +7.41% |
50-Day Moving Average | 78.18 |
200-Day Moving Average | 80.23 |
Relative Strength Index (RSI) | 63.27 |
Average Volume (20 Days) | 3,277,193 |
Short Selling Information
The latest short interest is 8.69 million, so 1.31% of the outstanding shares have been sold short.
Short Interest | 8.69M |
Short Previous Month | 8.07M |
Short % of Shares Out | 1.31% |
Short % of Float | 1.57% |
Short Ratio (days to cover) | 2.54 |
Income Statement
In the last 12 months, MetLife had revenue of $73.01 billion and earned $4.09 billion in profits. Earnings per share was $5.93.
Revenue | 73.01B |
Gross Profit | 18.78B |
Operating Income | 6.54B |
Pretax Income | 3.69B |
Net Income | 4.09B |
EBITDA | 7.25B |
EBIT | 6.54B |
Earnings Per Share (EPS) | $5.93 |
Full Income Statement Balance Sheet
The company has $30.48 billion in cash and $47.96 billion in debt, giving a net cash position of -$25.78 billion or -$38.76 per share.
Cash & Cash Equivalents | 30.48B |
Total Debt | 47.96B |
Net Cash | -25.78B |
Net Cash Per Share | -$38.76 |
Equity (Book Value) | 27.93B |
Book Value Per Share | 41.52 |
Working Capital | 28.71B |
Full Balance Sheet Cash Flow
Operating Cash Flow | 15.23B |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 25.73%, with operating and profit margins of 8.95% and 5.87%.
Gross Margin | 25.73% |
Operating Margin | 8.95% |
Pretax Margin | 7.82% |
Profit Margin | 5.87% |
EBITDA Margin | 9.93% |
EBIT Margin | 8.95% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $2.27, which amounts to a dividend yield of 2.79%.
Dividend Per Share | $2.27 |
Dividend Yield | 2.79% |
Dividend Growth (YoY) | 4.46% |
Years of Dividend Growth | 12 |
Payout Ratio | 37.55% |
Buyback Yield | 6.05% |
Shareholder Yield | 8.84% |
Earnings Yield | 7.56% |
FCF Yield | n/a |
Dividend Details Analyst Forecast
The average price target for MetLife is $95.60, which is 17.50% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $95.60 |
Price Target Difference | 17.50% |
Analyst Consensus | Strong Buy |
Analyst Count | 10 |
Revenue Growth Forecast (5Y) | 5.18% |
EPS Growth Forecast (5Y) | 20.86% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 6 |